245 related articles for article (PubMed ID: 17616676)
1. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
2. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.
Yeh S; Miyamoto H; Nishimura K; Kang H; Ludlow J; Hsiao P; Wang C; Su C; Chang C
Biochem Biophys Res Commun; 1998 Jul; 248(2):361-7. PubMed ID: 9675141
[TBL] [Abstract][Full Text] [Related]
4. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
[TBL] [Abstract][Full Text] [Related]
5. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor suppressor dysregulation in prostate cancer progression.
Dean JL; Knudsen KE
Curr Drug Targets; 2013 Apr; 14(4):460-71. PubMed ID: 23410128
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.
Gao S; Gao Y; He HH; Han D; Han W; Avery A; Macoska JA; Liu X; Chen S; Ma F; Chen S; Balk SP; Cai C
Cell Rep; 2016 Oct; 17(4):966-976. PubMed ID: 27760327
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
9. AR, the cell cycle, and prostate cancer.
Balk SP; Knudsen KE
Nucl Recept Signal; 2008 Feb; 6():e001. PubMed ID: 18301781
[TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.
Bosco EE; Wang Y; Xu H; Zilfou JT; Knudsen KE; Aronow BJ; Lowe SW; Knudsen ES
J Clin Invest; 2007 Jan; 117(1):218-28. PubMed ID: 17160137
[TBL] [Abstract][Full Text] [Related]
11. Induction of androgen receptor-dependent apoptosis in prostate cancer cells by the retinoblastoma protein.
Wang X; Deng H; Basu I; Zhu L
Cancer Res; 2004 Feb; 64(4):1377-85. PubMed ID: 14973061
[TBL] [Abstract][Full Text] [Related]
12. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
Reed MF; Zagorski WA; Knudsen ES
J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
14. Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.
Dean JL; McClendon AK; Stengel KR; Knudsen ES
Oncogene; 2010 Jan; 29(1):68-80. PubMed ID: 19802012
[TBL] [Abstract][Full Text] [Related]
15. E2F activity is biphasically regulated by androgens in LNCaP cells.
Hofman K; Swinnen JV; Verhoeven G; Heyns W
Biochem Biophys Res Commun; 2001 Apr; 283(1):97-101. PubMed ID: 11322773
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
17. The Role of RB in Prostate Cancer Progression.
Burkhart DL; Morel KL; Sheahan AV; Richards ZA; Ellis L
Adv Exp Med Biol; 2019; 1210():301-318. PubMed ID: 31900914
[TBL] [Abstract][Full Text] [Related]
18. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
19. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
20. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
